Latest Insider Transactions at Avidity Biosciences, Inc. (RNA)
This section provides a real-time view of insider transactions for Avidity Biosciences, Inc. (RNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Avidity Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Avidity Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2020
|
Troy Edward Wilson Director |
SELL
Other acquisition or disposition
|
Direct |
100,000
-52.74%
|
-
|
|
Jun 16
2020
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
300,000
+10.66%
|
$5,400,000
$18.0 P/Share
|
|
Jun 16
2020
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
2,214,545
+50.0%
|
-
|
|
Jun 16
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
950,000
+19.21%
|
$17,100,000
$18.0 P/Share
|
|
Jun 16
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,045,000
+50.0%
|
-
|
|
Jun 16
2020
|
Lilly & CO Eli |
BUY
Conversion of derivative security
|
Direct |
2,169,396
+50.0%
|
-
|